The Transcriptional Specificity of NF-κB Dimers Is Coded within the κB DNA Response Elements  by Wang, Vivien Ya-Fan et al.
Cell Reports
ArticleThe Transcriptional Specificity of NF-kB Dimers
Is Coded within the kB DNA Response Elements
Vivien Ya-Fan Wang,1 Wendy Huang,2,4 Masataka Asagiri,1,3,5 Nathanael Spann,2 Alexander Hoffmann,1,3
Christopher Glass,2 and Gourisankar Ghosh1,*
1Department of Chemistry and Biochemistry
2Department of Cellular and Molecular Medicine, School of Medicine
3Signaling Systems Laboratory
University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA
4Present address: New York University Medical Center, 540 First Avenue, Skirball 2-17, New York, NY 10016, USA
5Present address: Innovation Center for Immunoregulation and Therapeutics, Graduate School of Medicine, Kyoto University,
Yoshida Konoe, Sakyo-ku, Kyoto 606-8501, Japan
*Correspondence: gghosh@ucsd.edu
http://dx.doi.org/10.1016/j.celrep.2012.08.042SUMMARY
Nuclear factor kB (NF-kB) regulates gene expression
by binding to specific DNA elements, known collec-
tively as kB sites, that are contained within the
promoters/enhancers of target genes. We found
that the identity of the central base pair (bp) of kB
sites profoundly affects the transcriptional activity
of NF-kB dimers. RelA dimers prefer an A/T bp at
this position for optimal transcriptional activation
(A/T-centric) and discriminate against G/C-centric
kB sites. The p52 homodimer, in contrast, activates
transcription from G/C-centric kB sites in complex
with Bcl3 but represses transcription from the A/T-
centric sites. The p52:Bcl3 complex binds to these
two classes of kB sites in distinct modes, permitting
the recruitment of coactivator, corepressor, or both
coactivator and corepressor complexes in pro-
moters that contain G/C-, A/T-, or both G/C- and
A/T-centric sites. Therefore, through sensing of bp
differences within kB sites, NF-kB dimers modulate
biological programs by activating, repressing, and
altering the expression of effector genes.
INTRODUCTION
The nuclear factor kB (NF-kB) family of transcription factors re-
gulates the transcription of a vast collection of inducible effector
genes whose coordinated function results in signal-dependent
cellular responses to diverse stimuli (Hoffmann et al., 2006).
Despite >25 years of intensive study, it is still not clear how, or
even whether, the precise DNA sequences targeted by various
NF-kB dimers direct gene expression levels in response to signal
transduction in vivo.
Five NF-kB familymember subunits (p50, p52, RelA/p65, cRel,
and RelB) assemble combinatorially into functioning homo- and
heterodimers that bind a set of specific DNA elements, known
as kB sites, in the enhancers/promoters of target genes. DNA
binding activity is confined to a highly conserved 300-residue824 Cell Reports 2, 824–839, October 25, 2012 ª2012 The Authorsregion, referred to as the rel homology region (RHR), that is
present near the N termini of NF-kB subunits. Initial discovery
and characterization of several physiological kB sites estab-
lished the pseudo-symmetric consensus kB site as 50-GGGRN
W YYCC-30 (R = purines, N = any nucleotide, W = adenine or
thymine, and Y = pyrimidine). X-ray crystal structures of several
distinct NF-kB homo- and heterodimers in complex with dif-
ferent kB sites revealed that diverse NF-kB dimers recognize
kB sites through a relatively conserved mode in which the RHR
of each monomer mediates base-specific contacts through the
DNA major groove to one half site wherein the flanking (G)GG/
(C)CC sequences are contacted by a set of invariant residues.
The inner, more variable base pairs (bps) participate in less
conserved interactions with the NF-kB subunits (Figure 1A).
Expanded genomic analyses have led to the identification of
a large number of kB sites present within promoter/enhancer
(cis-regulatory) regions of several hundred genes. In vitro binding
experiments have been carried out to classify these kB sites
according to their binding specificity for different NF-kB dimers.
These analyses led to the observation that the binding affinity
displayed by the various NF-kB dimers for distinct kB sites does
not necessarily correlate with what occurs during regulation of
gene expression by NF-kB in vivo. For example, the p50/RelA
heterodimer binds tightly to most kB sites, whereas RelA and
cRel homodimers bind to many of the same sites with relatively
low affinity. However, ablation of nfkb1 p105/p50 or nfkb2 p100/
p52 genes in mice does not greatly affect the expression of
NF-kB target genes, suggesting that RelA and cRel homo- and
heterodimers alone are sufficient for the transcriptional activa-
tion. Other detailed genetic experiments have shown that some
genes are activated only in the presence of one or a subset of
NF-kB subunits (Hoffmann et al., 2003; Natoli et al., 2005; Ogawa
et al., 2005). Structural and biochemical analyses of DNA binding
by NF-kB dimers have also revealed the existence of a large
number of kB sites that display relatively similar affinities com-
pared with consensus kB sites even though they lack one con-
sensus half site entirely (Ghosh et al., 2012; Siggers et al., 2012).
It was demonstrated that a single bpdifference between the kB
sites within IFN-gamma-inducible protein 10(IP-10) and mono-
cyte chemoattractant protein 1 (MCP-1) promoters alters the
genes’ responsiveness to different NF-kB dimers (Leung et al.,
2004). Whereas both p50/RelA heterodimer and RelA homo-
dimer can activate MCP-1 gene expression, only the hetero-
dimer can activate IP-10 gene expression under specific
conditions. Interestingly, both RelA homodimer and p50/RelA
heterodimer bind both of these kB sites with similar affinities
in vitro. It was shown that coactivator recruitment differs
between the two promoters (Leung et al., 2004). A later report
supported these observations by showing promoter-specific
activity of RelA (Ogawa et al., 2005).
In addition to dimer-specific gene activation, NF-kB also
represses transcription. For example, RelA represses expression
of the nrp1 gene, which is essential for osteoclast differentiation
(Hayashi et al., 2012). Interestingly, the sequence of the RelA-
repressive kB site displays significant deviation from the
consensus in one of its half sites. The p50 homodimerwas shown
to repress interferon-stimulated response element (ISRE) sites
(Cheng et al., 2011). These sites also display only half-site
similarity to the kB consensus. Taken together, these reports
strongly suggest that kB sites may dictate NF-kB transcriptional
outcomes. However, no systematic analysis has been carried out
to define the link among the kB site sequence, NF-kB dimer
binding specificity, and regulation of target gene expression.
Using in vitro binding, cell-based gene expression, and bio-
informatic experiments, we show the following: (1) kB sites can
be classified into two distinct classes based on the bp identity
of the central position. (2) The transcriptional responses of
RelA dimers and p52 homodimer complexed to Bcl3 (henceforth
referred to as the p52:Bcl3 complex) are different for two classes
of kB sites. RelA dimers bind G/C-centric sites poorly in vitro and
fail to activate transcription from these sites in vivo; instead, RelA
dimers activate transcription by binding to A/T-centric sites.
However, the p52:Bcl3 complex activates transcription by bind-
ing to G/C-centric sites. Strikingly, the same complex represses
transcription by binding to A/T-centric sites. (3) The p52:Bcl3
complex accomplishes this dual feat by recruiting coactivator
and corepressor complexes to G/C- and A/T-centric sites, re-
spectively. The same NF-kB complex thus can simultaneously
activate and repress distinct kB sites located in the same pro-
moter where the strength of activation and repression dictates
the overall outcome. (4) In vitro experiments reveal that the
p52:Bcl3 complex binds to these kB sites in distinct modes,
presumably because of the distinct structural states imposed
by the sequence difference. Structural studies revealed that
the central bp of a kB DNA does not make base-specific con-
tacts with NF-kBdimers, which suggests that the conformational
state of kB sites is an essential component of gene regulation
specificity. Overall, this study provides the underpinnings of
a model that integrates kB site sequence, NF-kB dimer selec-
tivity, and regulation of target gene expression.
RESULTS
The Central bp of kBDNA Sequences Plays a Key Role in
Providing the Transcriptional Activity of NF-kB Dimers
To investigate whether NF-kB dimers select specific kB sites for
transcriptional activity, we searched for promoters that are strin-
gently regulated by specific dimers. It was previously shown that
the promoters of P-selectin and CyclinD1 are specifically boundCby the p52 homodimer (Guttridge et al., 1999; Pan and McEver,
1995). Along with p52, these promoters also require Bcl3, which
is consistent with the notion that p52 alone, lacking an activation
domain, cannot activate transcription as a homodimer. p52
and Bcl3 are also involved in the transcriptional regulation of
S-phase kinase-associated protein 2 (Skp2), IP-10, and inter-
leukin 10 (IL-10) genes (Barre´ and Perkins, 2007; Leung et al.,
2004; Mu¨hlbauer et al., 2008). Two kB sites are known to regu-
late IP-10 gene expression, but neither of them is specifically
linked to the p52:Bcl3 complex. To date, no kB sites that drive
NF-kB-dependent activation of IL-10 and Skp2 genes are
known. We identified kB sites within IL-10 and Skp2 promoters
by searching sequences from 10 kb to +1 kb of the transcrip-
tion start site of these genes. Alignment of the kB sites of these
five promoters (P-selectin, CyclinD1, IP-10, IL-10, and Skp2)
revealed that all five contain at least one G/C-centric kB site
(Figure 1B). Because nearly all known kB sites contain A/T bp
at the central position, we set to investigate whether the central
bp is a critical determinant of transcriptional specificity of the
p52:Bcl3 complex. Luciferase reporter constructs with either
natural (G/C-centric) or mutant (A/T-centric) bp for all five of
these kB sites were generated. In all cases, the G/C-centric kB
sites induced luciferase expression in the presence of both
p52 and Bcl3 (Figures 1C–1G). Deletion of the N and/or C
terminus of Bcl3 nearly abolished luciferase activity, further
signifying the critical role of Bcl3 (Figures S1A–S1C). Conversion
of the central G/C to A/T bp reduced luciferase expression,
although the extent of reduction varied. All natural G/C-centric
kB sites were discriminated by RelA. In some cases, alteration
of G/C to A/T bp of these sites enhanced luciferase expression
in response to RelA. These observations support the notion
that, at least in the in vitro system, the central bp in kB sites plays
an important role in imposing NF-kB dimer function. Several
other NF-kBdimers were also tested for their transcriptional acti-
vation specificity. Again, we observed that only the p52:Bcl3
complex was able to drive luciferase expression from this site
(see Figures S1E–S1G; Extended Results).
We further tested two well-characterized kB sites: the HIV-kB
site and the major histocompatibility complex (MHC)-kB site. As
shown in Figure 1H, RelA activates the wild-type (WT) A/T-
centric HIV-kB site but not the mutant G/C-centric HIV-kB
site. However, the p52:Bcl3 complex showed the opposite
activity. Similar effects were observed for the MHC-kB site (Fig-
ure S2A). Together, these observations suggest a dominant role
of the central bp in NF-kB dimer selectivity. RelA dimers select
A/T-centric sites for transcriptional activation, whereas the p52:
Bcl3 complex selects G/C-centric sites. However, it is noticeable
that the activation potential of RelA dimers from classical A/T-
centric sites is far greater than that of the p52:Bcl3 complex
from G/C-centric sites.
Architecture of the kB Sites in NF-kB Target Gene
Promoters
We next investigated the promoters of NF-kB target genes from
published literature and a database (http://bioinfo.lifl.fr/NF-KB/)
that has compiled promoters for over 100 mouse/human NF-
kB target genes. We also examined microarray data obtained
with the use of Kdo2-Lipid A (a synthetic lipid that has endotoxinell Reports 2, 824–839, October 25, 2012 ª2012 The Authors 825
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activity equal to that of LPS and activates macrophages via TLR-
4) and generated by the LIPID MAPS consortium (http://www.
lipidmaps.org/data/index.html). We focused on known NF-kB
target genes and inspected the sequences for the presence of
kB sites from 10 kb to +1 kb of the transcription start site (a
subset of these sites are listed in Figure 2A). The kB sites of
a large number of these genes have not been annotated previ-
ously. We targeted several of these genes for further investiga-
tion (Figure 2A). Some of these promoters contain only classical
A/T-centric kB sites, and some contain only G/C-centric kB
sites, but most contain both A/T- and G/C-centric sites. From
this list, we tested three G/C-centric sites located in the pro-
moters of CD95Fas(FAS), CD40(TNFRSF5), and proteasome
subunit a2 (PSMA2) by reporter assay (Figures S2B–S2D). Our
analysis confirmed a strong correlation between G/C-centric
sites and their activation by the p52:Bcl3 complex. In addition,
RelA activated the mutant A/T-centric sites. However, alteration
of G/C to A/T at the central position did not significantly reduce
the p52:Bcl3 complex transcriptional activity in these three
cases, suggesting that other bps in kB sites also contribute to
gene regulation. That is, mutation in the context of naturally
occurring kB sites could not overpower the auxiliary effect of
other bps in the sequence. Further studies are required to assess
the role of the other bps in dimer specificity.
We used a lentiviral system that integrates NF-kB-driven
promoters with destabilized green fluorescent protein (dGFP)
expression as a reporter into the genome of monocyte THP-1
cells to further validate the transfection-based luciferase activity.
Using this lentivirus system, we generated stable THP-1 cell lines
with promoters containing WT HIV, P-selectin, and Skp2-kB
sites or their mutational variants, and measured dGFP expres-
sion in LPS-stimulated cells (Figure S2F; Extended Results).
Cells with G/C-centric P-selectin and Skp2-kB sites showed
low dGFP expression at 8 hr and higher expression at 24 hr;
however, the corresponding A/T mutants behaved in a manner
opposite to that of their WT counterparts. In sum, the lentiviral
and transfection-based reporter results are consistent. These
observations allowed us to speculate that the early induction
was likely to be mediated by RelA dimers, whereas the late
expression was mediated by the p52:Bcl3 complex.
To test whether the promoters are similarly regulated in the
endogenous context as depicted in the artificial reporter sys-
tems, we used the RAW 264.7 macrophage cell line as a model
system. This cell line has been extensively investigated for its
LPS-responsive gene regulation program by NF-kB (Lee et al.,
2006; Ogawa et al., 2005; Wessells et al., 2004). Two eventsFigure 1. NF-kB Dimers Recognize kB Sites Using a Conserved Mode,
Sites
(A) Cartoon representation of conserved base-specific contacts between an NF
marked in green and yellow. Invariant Pro residue (boxed in yellow)makes van der
bonding contacts. His residues in the box are present only in p50 and p52, replace
and p52, and Arg in RelA, cRel, and RelB at equivalent positions.
(B) Sequences of kB DNAs. Top: Consensus of known kB sites (the two half-sites
known A/T-centric kB sites; middle: G/C-centric kB sites; right: newly identified
(C–H) Luciferase reporter activity driven by a promoter containing a single WTG/C
(E), IP-10 proximal kB site (F), IL-10 kB site (G), and WT A/T- or mutant G/C-centr
RLU, relative luciferase unit. *p < 0.05, **p < 0.01. Error bars represent SD.
See also Figure S1 and Table S3.
Ccontrol the gene activation profiles: the kinetics of activation of
specific NF-kB subunits, and their selectivity toward kB sites.
Therefore, the activation kinetics of p52 and Bcl3 are expected
to converge in order for them to function together. Indeed, we
found nuclear accumulation of Bcl3 and p52 at 8–12 hr after
LPS induction (Figures 2B and 2C). In contrast, nuclear RelA
peaked between 1 and 2 hr, and slowly diminished afterward.
These observations suggest that early-induced genes may be
activated by RelA through binding to A/T-centric kB sites,
whereas late-activated genes may be induced by the p52:Bcl3
complex through binding to the G/C-centric kB sites. Promoters
that contain both types of kB sites would be persistently acti-
vated, at the early stage by RelA and at the late stage by the
p52:Bcl3 complex.
The p52:Bcl3 Complex Is Recruited to Both G/C- and
A/T-centric kB Sites, with Opposite Transcriptional
Outcomes
To validate our hypothesis regarding kB-site selectivity in cells,
we carried out chromatin immunoprecipitation (ChIP) assays on
several promoters that contain at least one G/C-centric kB site.
Both p52 and Bcl3 were bound to IL-10, MIP-1a, MIP-1b, IP-
10, MCP-1, CD95Fas, CD40, A20, and IL-1 receptor antagonist
(IL-1RN) promoters at 12 hr, but were significantly less bound
at 2 hr of LPS induction (Figures 3A1–3E1 and S3B). We also
tested a subset of these promoters for RelA binding. With the
exception of CD40, RelA bound to these promoters at 2 hr but
not at 12 hr. We also found that RNA Pol II is recruited to these
promoters, suggesting that these promoters are transcriptionally
active (Figures 3A2–3F2). The pattern of DNA binding by the
NF-kBdimers is consistentwith the promoter architecture. These
results led us to propose that A/T-centric kBsites primarily recruit
RelA dimers at early times after LPS stimulation, whereas G/C-
centric kB sites recruit the p52:Bcl3 complex at late stages.
Two promoters, IL-23p19 and IL-6, which do not contain any
G/C-centric kB sites, were also tested. A ChIP assay confirmed
that both p52 and Bcl3 occupied the IL-23p19 promoter at
12 hr of LPS induction (Figure 3F). However, RNA Pol II was not
recruited to this promoter, suggesting transcriptional silencing.
This result also suggests that the recruitment of p52 and Bcl3
may lead to promoter silencing. Surprisingly, the IL-6 promoter,
which contains an A/T-centric kB site, did not recruit either p52
or Bcl3 (Figure S3B). IL-6 is known to be activated by the
p50:IkBz complex in macrophages (Yamamoto et al., 2004).
Therefore, at least a subset of A/T-centric sites are regulated
by NF-kB dimers other than RelA and the p52:Bcl3 complex.and the p52:Bcl3 Complex Activates Reporters with G/C-Centric kB
-kB dimer and a kB DNA. The RHR regions of the two NF-kB monomers are
Waals contacts. Invariant Tyr residuemakes both van derWaals and hydrogen-
d by an Ala in RelA, cRel, and RelB. Arg/Lys denotes the presence of Lys in p50
are marked by ± 1 to ± 4/5, and the central position is marked by 0; left: well-
G/C-centric kB sites.
- or mutant A/T-centric P-selectin kB site (C), cyclin D1 kB site (D), Skp2 kB site
ic HIV kB site (H) cotransfected with vectors expressing p52 and Bcl3 or RelA.
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Figure 2. Promoter Architecture and LPS-Mediated NF-kB Activation
(A) Identification of kB sites in the promoter/enhancer region of knownNF-kB target genes. Genes with newly identified kB sites are indicated in red. A/T and G/C-
centric kB sites are indicated by white and black boxes, respectively.
(B) Western blot analysis of nuclear and cytoplasmic extracts of RAW 264.7 cells after LPS stimulation for different times. RelA accumulation in the nucleus
peaked between 1 to 2 hr of LPS stimulation; Bcl3 and p52 accumulated in the nucleus at later time points; peaked at 8–12 hr of LPS stimulation.
(C) ChIP assay showing p52 loading onto the Skp2 promoter in RAW 264.7 cells treated with LPS for the indicated times. *p < 0.05. Error bars represent SD.
See also Figure S2 and Table S1.We next tested whether the kinetics of gene expression
correlates with the recruitment of the NF-kB complexes (Figures
3A3–3F3 and S3A; Extended Results). In agreement with the
microarray data obtained with Kso2-Lipid A and generated by
the LIPIDMAPS consortium, quantitative RT-PCR (qRT-PCR) re-
vealed that all of the tested genes, with the exception of IL-
23p19, were expressed in macrophages by LPS stimulation.
However, the amplitudes and kinetics of expression varied.
The IP-10 messenger RNA (mRNA) level showed prolonged828 Cell Reports 2, 824–839, October 25, 2012 ª2012 The Authorsinduction from 2 to 12 hr, with a peak at 2 hr, suggesting a contin-
uous transcription from the early to late phases of induction. The
early massive IP-10 induction is probably due to RelA recruit-
ment, whereas the late induction results from p52:Bcl3 recruit-
ment. In other test cases, the expression pattern was different.
The mRNA levels were lower at early times than at late times.
CD40 was activated at early times of LPS induction; however,
RelA was not recruited to this promoter, suggesting that other
NF-kB subunits, such as cRel, may have compensated for
Figure 3. p52 and Bcl3 Binding to Endoge-
nous Promoters, and Gene Activation upon
LPS Stimulation
(A1–F1) ChIP assay showing recruitment of p52,
Bcl3, and RelA to indicated promoters at different
times in RAW 264.7 cells untreated or treated with
LPS for the indicated times.
(A2–F2) ChIP assay showing recruitment of RNA
Pol II in RAW 264.7 cells treated with LPS at the
indicated times. *p < 0.05, **p < 0.01.
(A3–F3) mRNA levels of the same set of genes
monitored by qRT-PCR in RAW 264.7. **p < 0.01,
***p < 0.001 versus untreated controls. Error bars
represent SD.
See also Figure S3 and Tables S1 and S2.
Cell Reports 2, 824–839, October 25, 2012 ª2012 The Authors 829
830 Cell Reports 2, 824–839, October 25, 2012 ª2012 The Authors
RelA’s function at early times. Consistent with the fact that IL-
23p19 contains three A/T-centric kB sites, we found that the
expression of IL-23p19 was completely blocked even though
both p52 and Bcl3 were recruited to the promoter upon LPS
induction. Altogether, these observations prompted us to pro-
pose an intriguing hypothesis: RelA activates genes from the
A/T-centric kB sites at early times; however, the co-occupancy
of p52 and Bcl3 in A/T-centric kB sites results in repression of
transcription, whereas it activates transcription by binding to
G/C-centric kB sites at late times.
The observation that the p52/RelB heterodimer is the key
dimer of noncanonical NF-kB signaling pathways raises the
question as to whether the p52/RelB heterodimer might also
be responsible for the late gene activation. We measured RelB
mRNA in both RAW 264.7 and bone-marrow-derived macro-
phages (BMDM), and found that RelB was induced early by
LPS and its levels were significantly lower at late times (Fig-
ure S3C). These observations are consistent with the results
shown in the LIPID MAPS, which showed that RelB levels were
only 1.47- and 1.28-fold higher at 8 and 12 hr after stimulation,
suggesting that RelB dimers were not significantly activated by
LPS in macrophages during the timeframe investigated in this
study. Altogether, these observations suggest that p52:Bcl3 is
a key NF-kB complex that is responsible for regulating kB sites
at late times. Moreover, unlike stimuli such as LTb, which strin-
gently activates the noncanonical NF-kBpathway, LPS activates
both the canonical and noncanonical pathways. Therefore,
dimers that are activated and regulated by LPS are expected
to be different from those activated only through the noncanon-
ical pathway.
Bcl3 Is Essential for p52-Mediated Transcriptional
Regulation
To further confirm the role of the p52:Bcl3 complex in gene regu-
lation, we carried out small interfering (siRNA)-mediated Bcl3
knockdown in BMDM and tested how it affects target gene
expression. We found that NF-kB target genes that were ex-
pressed in RAW 264.7 cells were also expressed in BMDM (Fig-
ure S4B), although the amplitude and kinetics of expression
varied. For instance, Bcl3 levels were highest at 8 hr, and most
target genes showed the highest levels at 8 hr in BMDM,
compared with 12 hr in RAW 264.7 cells. We were able to obtain
70% siBcl3 knockdown compared with control scramble
siRNA (Figure S4A). We performed qRT-PCR to test 18 NF-kB
target genes for their Bcl3 responsiveness. In LPS-stimulated
cells, the mRNA levels of some genes were repressed (IL-10,
MCP-1, MIP-1a, MIP-1b, MIP-2, RANTES, and IL-1b; Figure 4A),
some were enhanced (IP-10, CD40, CD95Fas, nfkb2, IL-1RN,
IL-15, IL-27p28, and A20; Figure 4B), and three remained
unchanged (IL-6, IL-1a, and MCP-3; Figure 4C). These observa-Figure 4. Bcl3 Is Essential for Target Gene Expressions
(A–C) mRNA levels showing genes that are (A) downregulated, (B) upregulated
*p < 0.05, **p < 0.01, ***p < 0.001 versus nontreated control or as indicated. Erro
(D) Microarray mRNA expression data from mouse scramble siRNA (siCTL) and
K-means clustering. Red represents stimulus-responsive gene induction, whereas
the red symbol indicating clusters with increased expression in siBcl3 cells com
See also Figure S4 and Table S2.
Ctions further support the notion that the p52:Bcl3 complex not
only activates transcription but also represses gene transcrip-
tion. Because IL-10, MIP-1a, and MIP-1b contain only a single
G/C-centric kB site, repression of these genes in siBcl3 cells
clearly suggests a critical transcriptional activation role of the
p52:Bcl3 complex. The expression profiles of other genes in
this category (containing both A/T- and G/C-centric sites) that
are repressed in siBcl3 cells suggested that the activation func-
tion of the p52:Bcl3 complex is dominant over its repression
function. The second class of genes was activated upon siBcl3,
suggesting that the repression function of the p52:Bcl3 complex
from the A/T-centric sites is dominant over its activation function
from the G/C-centric sites. The third class of genes was not
sensitive to siBcl3, which suggests that other NF-kB dimers
could play a role in their activation. For example, IL-6 was shown
to be activated by the p50:IkBz complex. Further investigation is
required to understand the responsiveness of each kB DNA to
different NF-kB dimers.
To further test our hypothesis on an unbiased, genome-wide
scale, we profiled gene induction and repression by LPS stimu-
lation (0 or 8 hr) in siBcl3 BMDM compared with that in siCTL
cells by microarray analysis. LPS-stimulated samples at 8 hr
were used because Bcl3 levels were highest at this time of
induction in WT BMDM. Genes with 1.5-fold enhanced acti-
vation or repression upon siBcl3 were selected. Genes that
showed a change in basal-level activation or repression but
no change post-LPS stimulation were excluded from analysis.
K-means clustering was performed with selected 184 genes
(Figure 4D), which resulted in eight clusters that were further
categorized based on the extent of activation or repression.
This resulted in four main categories: genes that were activated
in siCTL samples that were further activated (Figure 4D, clusters
C, E, and G) or repressed (clusters A and D) in siBcl3 cells, and
genes that showed no change in siCTL samples but were acti-
vated (Figure 4D, clusters B and F) or repressed (cluster H) in
siBcl3 cells. All of the target genes tested by qRT-PCR (Figures
4A–4C) showed similar expression patterns in microarray anal-
ysis. The biological functions of more than two-thirds of these
184 genes are known. Collectively, these gene products are
known for their activities in inflammation, growth and prolifera-
tion, vascular function, hemoglobinmetabolism, and redox regu-
lation. Proinflammatory genes (Nos2, Ptgs2, Ptges, CD69, and
Vcam1), antiproliferation genes (Slfn1, Dnajb6, and Jdp2), and
genes that regulate vascular activity (Itga5, Vegfa, Cxcl4, Tpbg,
collagen, and Mmp13/14) are activated in siBcl3 cells listed in
clusters B, C, and E. Growth- and proliferation-promoting genes
(Egr1,Dek,CD74,Ccnd1, Areg,Dusp6,Gdf15, Ptpre, and Lmna)
are downregulated, as are the genes encoding redox and pH-
sensing enzymes (Hmox1, Sepp1, Srxn1, and Hvcn1) listed in
clusters A, D, and H. These observations are consistent with, or (C) unaffected upon siBcl3 knockdown in BMDM by qRT-PCR analysis.
r bars represent SD.
siBcl3 BMDM cells stimulated with LPS (100 ng/ml) for 8 hr were analyzed by
green represents repression. Cluster identifiers are indicated on the right, with
pared with siCTL cells.
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earlier reports that the p52:Bcl3 complex promotes cell prolifer-
ation (Brenne et al., 2009; Massoumi et al., 2006; Ong et al.,
1998; Rocha et al., 2003; Westerheide et al., 2001); however,
the significance of NF-kB/Bcl3 in redox and pH sensing remains
to be established. In addition, the Samhd1 gene, an HIV-1 re-
striction factor that encodes deoxynucleoside triphosphatase,
was upregulated in siBcl3, suggesting an inhibitory role of Bcl3
in HIV infection (Figure S4C).
Although most of the siBcl3-affected genes are functionally
connected to NF-kB, it is not clear whether their expression is
directly regulated by NF-kB. We randomly picked 28 genes
that showed significant up- or downregulation in the microarray
NF-kB binding-site analysis, and found that they all contain kB
sites and most of them contain multiple sites (Figure S4E). The
expression profiles of some of these genes are shown in Figures
S4C–S4D. Genes that are upregulated contain predominantly or
exclusively A/T-centric sites, whereas genes that are downregu-
lated contain both A/T- and G/C-centric sites. Without a func-
tional analysis, one cannot be certain that these genes are
regulated by the p52:Bcl3 complex; however, in general, the
genome-wide analysis further strengthens our hypothesis that
the G/C-centric sites are activated by the p52:Bcl3 complex,
whereas A/T-centric sites are repressed by the same complex.
As mentioned above, the activity of the p52:Bcl3 complex on
promoters containing both types of kB sites is expected to be
determined by the combinatorial effect of the relative strengths
of each site.
Bcl3 Alters the Mode of Interaction between the p52
Homodimer and Two Classes of kB Sites In Vitro
To further assess whether the p52:Bcl3 complex senses A/T-
and G/C-centric kB sites differently, we carried out in vitro
DNA-binding experiments using the electrophoretic mobility
shift assay (EMSA). Surprisingly, we found that the p52 homo-
dimer bound to the A/T-centric kB sites with higher affinity
than the G/C-centric sites. To test whether Bcl3 reverses this
effect, we used both Bcl3-transfected nuclear extracts (NE)
and affinity-purified Flag-tagged Bcl3 from HEK293T cells, and
tested the binding of the p52:Bcl3 complex to five WT G/C-
and corresponding mutant A/T-centric kB sites (P-selectin,
Skp2, IP-10, CyclinD1, and IL-10; Figures 5 and S5A–S5D). We
also tested WT A/T- and corresponding mutant G/C-centric kB
sites of HIV, IL-23p19, and MHC (Figures S5E–S5G). Contrary
to our expectation, we found that with increasing concentrations
of Bcl3, the p52:G/C-centric P-selectin kB DNA complex disap-
peared with no visible ternary complex in the gel (Figure 5A,
lanes 16–20). This behavior is reminiscent of IkBa-mediated inhi-
bition of DNA binding by RelA or p50/RelA heterodimer. IkBa
actively dissociates the RelA:DNA complex, forming the IkBa:
RelA complex and liberating free DNA. In this case, however,
no enhancement of free P-selectin kB probe with increasing
amounts of Bcl3 was observed, suggesting that the p52:DNAFigure 5. EMSA of p52, p52:Bcl3, and RelA on WT G/C-Centric or Muta
(A) Recombinant p52, RelA, and Flag-tagged full-length Bcl3 protein or NE bindi
kB:kBDNA binary complex, the double arrowhead denotes the p52:Bcl3:kBDNA
(B) Recombinant p52, RelA, Flag-tagged Bcl3 protein or NE binding to mutant (A
See also Figure S5 and Table S3.
Ccomplex does not dissociate (Figure 5A, light exposure, lanes
22–25). Antibody supershift identified distinct slow-mobility
complexes in the presence of antibodies against both anti-
Bcl3 and anti-p52 (Figure 5A). This suggested that although no
ternary complex was visible, both proteins were bound to the
probe simultaneously. In contrast, association between A/T-
centric kB DNA with p52 and Bcl3 was detected clearly as a
distinct slow-mobility complex (Figure 5B, lanes 16–20). The
presence of both proteins in this complex was also confirmed
by antibody supershift analysis. All other probes with G/C- and
A/T-centric kB sites showed similar trends (Figure S5). One
possible reason for the apparent absence of the ternary complex
between the G/C-centric kB site and the p52:Bcl3 complex is
its kinetic instability. Transient dissociation and reassociation
results in the lack of a discrete complex band in the gel. Antibody
binding alters the nature of the complex, resulting in a clear
supershifted band. We also noted that the CyclinD1 kB site
was the only exception in which both G/C- and A/T-centric
probes revealed nearly similar behaviors with no visible ternary
complex in the gel (Figure S5C). However, in both cases, anti-
body supershift confirmed the presence of both proteins.
CyclinD1-kB site differs significantly from most other kB sites.
The presence of one T-rich half site may influence the stability
of the (p52:Bcl3):CyclinD1-kB DNA complex. This may explain
why both WT G/C- and mutant A/T-centric CyclinD1 luciferase
reporters were transcriptionally active, as shown earlier (Fig-
ure 1D). On the other hand, we found that both WT A/T- and
mutant G/C-centric MHC-kB sites formed stable ternary com-
plexes, although the complex with the mutant G/C-centric kB
site was less prominent (Figure S5G). Consistent with these
observations, we found that bothWT andmutantMHC luciferase
reporters were somewhat defective in the p52:Bcl3-driven acti-
vation (Figure S2A). We suggest that whereas the identity of
the central bp is a crucial determinant of the transcriptional
activity of the p52:Bcl3 complex, this bp works in conjunction
with other bps within the kB sites. Possibly, every bp in kB sites
plays a role in the determination of NF-kB dimer specificity.
Taken together, these experiments suggest that the p52:Bcl3
complex binds to two distinct types of kB sites with distinct
kinetic stabilities and/or conformations. We refer to this binding
difference as distinct binding modes, and suggest that the
different transcriptional outcomes are related to the binding
modes.
The p52:Bcl3 Complex Recruits Coactivators to G/C-
Centric Sites, and Corepressors to A/T-Centric kB Sites
We hypothesized that the distinct bindingmodes of the p52:Bcl3
complex allow it to interact with specific cofactors, such as core-
pressors to A/T-centric sites and coactivators to G/C-centric
sites. Earlier reports showed that Bcl3 recruits the Tip60 histone
acetyl transferase (HAT) complex to activate transcription (Baek
et al., 2002; Dechend et al., 1999). ChIP experiments showednt A/T-Centric P-Selectin kB DNAs
ng to WT (G/C)-centric P-selectin kB DNA. Single arrowheads denote the NF-
ternary complex, and * indicates the supershifted complex by specific antibody.
/T)-centric P-selectin kB DNA.
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Figure 6. Selective Recruitment of Cofactors to the Target Gene Promoters
(A) ChIP assay showing recruitment of Tip60 to IL-10, MIP-1a, MIP-1b, IP-10, MCP-1, A20 (2188), and IL-6 promoters, but not A20 (39) and IL-23p19
promoters in RAW 264.7.
(B) ChIP assay showing the recruitment of HDAC3 to the IP-10, MCP-1, A20 (39) and IL-23p19 promoters in RAW264.7. *p < 0.05, **p < 0.01, ***p < 0.001 versus
nontreated control or as indicated. Error bars represent SD.
See also Table S1.that indeed Tip60 was recruited to the IL-10, MIP-1a, MIP-1b,
IP-10, and MCP-1 promoters with kinetics of recruitment that
coincided with p52 and Bcl3 recruitment (Figure 6A). Although
this experiment did not specify whether Tip60 was recruited to
the G/C-centric sites in IP-10 and MCP-1 promoters, because
these promoters also contain A/T-centric kB sites; however,
the recruitment of Tip60 to the IL-10, MIP-1a, and MIP-1b kB
sites clearly suggested that Tip60 was recruited to the G/C-
centric sites. To further assess whether Tip60 was recruited to
the G/C-centric site of a promoter containing both A/T- and
G/C-centric sites, we chose to test A20 (TNFAIP3). In this pro-
moter, two kB sites are >2 kb apart from each other. Because
fragmentation generates on average 500 bp DNA fragments,
one can in principle show that Tip60 is specifically recruited to
G/C-centric sites (2,188) but not to A/T-centric sites (39).
Our results thus clearly demonstrate the specificity of G/C-
centric kB sites for Tip60 recruitment. Consistent with ourmodel,
no Tip60 was found to be recruited to the IL-23p19 promoter,
a pure A/T-centric kB promoter, even though the p52:Bcl3834 Cell Reports 2, 824–839, October 25, 2012 ª2012 The Authorscomplex was recruited. The lack of Tip60 recruitment to the
IL-6 promoter further supports the report that p50:IkBz is
primarily responsible for activation of the IL-6 gene (Yamamoto
et al., 2004).
To determine whether the converse is true (i.e., whether the
p52:Bcl3 complex recruits a corepressor complex to the A/T-
centric kB sites), we investigated the recruitment of repressors
to the same set of five promoters. Previous studies showed
that Bcl3 interacts with CtBP, HDAC3, and TBLR1, which are
part of the NCoR/SMRT corepressor complex (Choi et al.,
2010; Keutgens et al., 2010). Here we found the presence
of HDAC3, a histone deacetylase, in the IL-23p19 promoter
before induction, and it remained throughout the time of induc-
tion. In contrast, HDAC3 repressed the IL-10, MIP-1a, and
MIP-1b promoters preinduction but disappeared during the
course of LPS induction (Figure 6B). We next tested for the pres-
ence of HDAC3 in composite kB-site promoters such as IP-10,
MCP-1, and A20. We found a different pattern of HDAC3 recruit-
ment: postinduction recruitment was partial with respect to
preinduction in the IP-10 and MCP-1 promoters. Because the
A/T- and G/C-centric sites are close to each other in both cases,
we proposed that both p52:Bcl3:Tip60 and p52:Bcl3:HDAC3
complexes might be present in these promoters at late times
of induction. The A20 promoter clarified the kB-site specificity
for HDAC3. We found that HDAC3 was present at both sites in
the basal state, was absent at 2–8 hr, and then returned at
12 hr postinduction. HDAC3 recruitment at 12 hr coincided
with the recruitment of the p52:Bcl3 complex at 12 hr to the
A/T-centric site (39). HDAC3 was not recruited to the G/C-
centric site (2,188) postinduction. These observations allow
us to suggest that the transcriptional activation complex is
present on theG/C-centric site, whereas the repression complex
is present on the A/T-centric site. Altogether, our results suggest
that the p52:Bcl3 complex ‘‘senses’’ the DNA sequence differ-
ence and binds two classes of kB sites in distinct modes, and
thus recruits either coactivator or corepressor complexes, lead-
ing to opposite transcriptional outcomes.
DISCUSSION
Despite the wealth of basic biochemical knowledge that has
been gained, deciphering the underlying principle behind NF-
kB dimer-specific target gene activation has remained elusive,
for several reasons. The cis-regulatory regions of most NF-kB
target genes contain multiple nonidentical kB sites that function
noncooperatively (Giorgetti et al., 2010). Moreover, the majority
of NF-kB-inducing stimuli activate several NF-kB dimers. These
facts make the task of determining which dimer binds to which
kB sequence within a promoter/enhancer a challenge. Further-
more, no obvious correlation exists between a kB site and an
NF-kB dimer for selective binding in vitro. Through a detailed
examination of NF-kB target gene promoter sequences, loading
of specific NF-kB subunits onto the kB sites, and genome-wide
gene expression patterns (Figures 2A and S4), we show that the
identity of the bp at the central position of kB sites strongly
affects NF-kB dimer-specific target gene expression. NF-kB
dimers bind to different kB sequences with different binding
affinities and binding modes. In this study, we show that the
p52:Bcl3 complex binds to both A/T- and G/C-centric kB sites;
however, the binding affinities and binding modes are differ-
ent, leading to different transcriptional outcomes. The complex
recruits HDAC3 to the A/T-centric sites to repress transcrip-
tion and recruits Tip60 to the G/C-centric site to activate tran-
scription. The simultaneous recruitment of transcriptional coac-
tivators and corepressors to a composite promoter/enhancer
is a compelling finding. Here, we discuss how sequence varia-
tions affect the affinity and conformation of NF-kB:DNA com-
plexes, as well as the functional consequences of kB sequence
variations.
DNA Sequence Variations Affect NF-kB:DNA Complex
Affinity and Conformation
Previous structural and binding studies of NF-kB:kB DNA com-
plexes have provided some mechanistic insights into how kB
sequences affect affinity and conformation. Whereas the flank-
ing GC-rich sequences are mostly responsible for affinity and
kB selectivity, NF-kB dimers ‘‘read’’ the central bp indirectly.CThis indirect-readout mechanism has been shown to be crucial
for many protein-DNA recognition events (Chen-Park et al.,
2002; Meijsing et al., 2009). For instance, kB sites with AT-rich
sequences (A-2A-1A0T+1T+2 or A-2A-1T0T+1T+2) in the middle
segment undergo bending that is apparently essential for RelA
and cRel binding (Chen et al., 2000). If the AT richness is broken
with a G/C bp at the center, the bendability of the DNA is ex-
pected to be different and hence the protein:DNA complex
conformation would differ. It is important to note that A-2T-1A/
T0A+1T+2 sequences are not acceptable for RelA even though
they are AT rich. T at 1 and A at +1 positions not only alter
DNA bendability but also put incorrect function groups for RelA
to interact. Thus, variations with the inner positions of kB
sequences would significantly affect RelA and possibly cRel
binding. At the same time, variability in DNA bending would
also affect the conformations of NF-kB:DNA complexes. This
explains why RelA homodimer binds poorly to the P-selectin
kB site (with T at 1 and A at +1) but relatively better to other
G/C-centric sites.
Both p50 and p52 are more tolerant to sequence variability
within the inner positions. Remarkably, however, even p50 and
p52 read the central bp differently, as revealed by the structures
of p50 and p52 homodimers bound to two nearly identical kB
sites, with the only difference being at the central position (A/T
bp versus A/A mismatch; Cramer et al., 1997; Mu¨ller et al.,
1995). These variations allow us tomake some speculations (Fig-
ure S6): Conserved residues from the p50 and p52 subunits bind
identical DNA sites differently because the DNA-noncontacting
protein residues of these two subunits differ. Therefore, an argu-
ment can be made that the central bp transduces specific
contact networks, resulting in different protein conformations
at a distal surface. NF-kB subunits are sensitive to small varia-
tions in the kB sites because the RHR region of NF-kB, which
is responsible for both DNA binding and protein dimerization,
is bimodular (including the N-terminal domain and C-terminal
dimerization domain) and connected through a small linker
peptide. The relative flexibility of the modules enables the dimer
to scan far greater DNA conformational spaces to find correct
functional groups for direct contact compared with a single-
module DNA-binding domain as in other DNA-binding proteins.
This greater scanning ability helps NF-kB to bind diverse kB sites
with similar binding affinities (Ghosh et al., 2012). Therefore,
NF-kB:DNA complex conformation is distinct for distinct DNA
sites even when the bp difference between these sites is as small
as one.
The protein-DNA recognition process cannot be fully captured
by static structures derived from crystallographic studies. A
microsecond molecular simulation study of an A/T-centric kB
site embedded within a 20-bp-long DNA showed unusual DNA
structural transitions at the long timescales of the simulations
(Mura and McCammon, 2008). This study revealed that one of
the bases of the central bp flipped out of the DNA axis. It is likely
that the dynamic behavior of target DNA affects the binding
modes of a transcription factor, and that such differential binding
modes control the assembly of the larger transcription complex.
It appears that binding of the p52:Bcl3 complex to the G/C- and
A/T-centric kB sites is differentially regulated, resulting in kinetic
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Figure 7. Model Depicting Temporal Con-
trol of Target Genes by Different NF-kB
Dimers and Coactivator and Corepressor
Complexes
Promoters with A/T-centric kB site(s) are activated
by RelA supported by CBP/p300 at early times
after induction. Composite promoters containing
A/T- and G/C-centric kB sites are simultaneously
regulated by corepressor and coactivator com-
plexes nucleated by the p52:Bcl3 complex.involving A/T-centric sites (Figures 5 and S5). Whether the
binding behaviors are also different in vivo is not known.
However, the fact that the two types of kB sites recruit different
cofactors by binding to the same p52:Bcl3 complex in vivo
strongly suggests a link between modes of NF-kB binding to
the DNA sequence.
Transcriptional regulation through DNA allostery has been
observed in other transcription factors, such as glucocorticoid
receptor (GR), nuclear receptors, and Drosophila Hox family
transcription factors (Joshi et al., 2010; Meijsing et al., 2009;
Ogawa et al., 2005). Yamamoto and colleagues (2004) exten-
sively studied the transcriptional activity of GR for different target
genes. They found that the binding affinity between GR and its
response element did not correlate with transcriptional activity.
Instead, small variations in DNA sequence affected the confor-
mation of a loop within the DNA-binding domain. Mutations at
various positions within the loop had diverse effects on the
expression of different genes containing different GR-response
elements. Although the functional consequence is unclear, Ki-
tayner et al. (2010) found that a protein noncontacting bp in
the interior of the DNA response element forms Hoogsteen
bp when bound to transcription factor p53. They showed that
Hoogsteen bp alters the DNA shape, electrostatic potential,
and configuration of neighboring sequences, resulting in dif-
ferential protein-DNA interactions as compared with sequences
with non-Hoogsteen bp. Furthermore, a recent NMR study
showed that CA and TA base steps in DNA duplexes show tran-
sient formation of Hoogsteen bp (Nikolova et al., 2011). Such
sequence-specific continuous fluctuations in bp mode may
allow a transcription factor to bind two sequences differently, re-
sulting in distinct functional outcomes, as we observed in the
case of the p52:Bcl3 complex.
Functional Consequences of Sequence Variations in kB
Sites
This study provides insights into the mechanism of temporal
gene expression byNF-kBdimers. During early induction, preex-
isting RelA dimers (presumably the p50/RelA heterodimer) are836 Cell Reports 2, 824–839, October 25, 2012 ª2012 The Authorsactivated through degradation of proto-
typical IkB inhibitors, which in turn acti-
vate early response genes by binding to
the A/T-centric kB sites (Figure 7). Along
with many early response genes, RelA
activates several NF-kB and IkB genes,
such as nfkb2 p100/p52, bcl3, and IkBz
(Brasier et al., 2001), that contain A/T-centric sites. At the late phase of induction, the newly formed
p52:Bcl3 complex activates genes with G/C-centric kB sites
such as IL-10. Promoters that contain multiple kB sites, both
A/T- and G/C-centric, such as IP-10, MCP-1 and A20, would
persistently be activated by sequential engagement of different
NF-kB dimers/complexes, such as early activation by RelA
dimers and late activation by the p52:Bcl3 complex. However,
the extent of persistent activation is dictated by the strength of
each kB site. Our results are consistent with the report that kB
sites in a promoter/enhance act independently (Giorgetti et al.,
2010), and in line with another, earlier report showing that dif-
ferent NF-kB dimers bind to the same promoter at different
kinetics (Saccani et al., 2003). Transcriptional repression by the
p52:Bcl3 complex through its binding to the A/T-centric kB sites
prevents uncontrolled, prolonged activation. RelA is not the only
NF-kB dimer that activates target gene at early times. Genes
such as CD40, IL-6, and MCP-3 are not regulated by RelA in
macrophages. The p50:IkBz complex has been shown to acti-
vate IL-6. Sequences of the kB sites are different outside of
the central A/T bp. These variations may be sufficient for the
p50:IkBz complex to outcompete the p52:Bcl3 complex in cells.
It remains to be determined which NF-kB dimer represses the
A/T-centric IL-23p19 promoter. Future studies will reveal how
bps in other positions affect NF-kB recruitment and transcrip-
tional activity.
The kB sequence-specific gene regulatory dynamics of NF-kB
dictates the setting of biological programs. For instance, our
results clarify how the p52:Bcl3 complex participates in coordi-
nating biological programs, such as the control of inflammation
and proliferation. It controls inflammation by activating antiin-
flammatory cytokines such as IL-10 through binding to their
G/C-centric kB sites. At the same time, it can repress proinflam-
matory cytokines such as IL-23, IL-6, and IL-8, and other inflam-
matory factors such as NOS2, COX2, and prostaglandin E syn-
thase by binding to their A/T-centric kB sites. Our observation
is consistent with the report that p52 and Bcl3 jointly dampen
inflammation of effector genes that would otherwise undergo
uncontrolled expression, as seen in nfkb2/bcl3/ double
knockout mice (Zhang et al., 2007). Through highly selective
regulation of the G/C-centric kB sites within the promoters of
Skp2 and CyclinD1, the p52:Bcl3 complex controls cell prolifer-
ation. The transcriptional activation of CyclinD1 from a specific
kB site is well documented (Guttridge et al., 1999), and the
CyclinD1 kB site has G/C bp at the central position. Because
CyclinD1 and Skp2 promoters contain only G/C-centric kB
sites, the absolute requirement of p52 and Bcl3 for activation
and in turn cell-cycle regulation can now be properly explained
(Barre´ and Perkins, 2007). In addition to these two, our microar-
ray analysis identified new growth- and proliferation-promot-
ing genes: Egr1, Dek, CD74, Areg, Dusp6, Gdf15, Ptpre, and
Lmna. These genes are expressed at reduced levels in the
absence of Bcl3. They contain at least one G/C-centric kB site
in their promoters (Figure S4E), which further supports the para-
digm that the coordination of a biological program is controlled
at the level of the kB DNA response element of the effector
genes. Interestingly, several genes that inhibit cell-cycle pro-
gression, such as Slfn1, Dnajb6, and Jdp2, are activated in
siBcl3. All of these genes contain A/T-centric kB sites in their
promoters. Thus, the p52:Bcl3 complex regulates cell prolifera-
tion by activating genes that promote proliferation and repres-
sing genes that block proliferation by sensing the kB sites in their
promoters differently.
Our study also clarifies a long-standing confusion about the
function of Bcl3. Some earlier reports showed that, like the
classical IkBs, Bcl3 could dissociate its preferred p50 or p52
homodimer from kB DNAs and thus function as a repressor of
transcription (Nolan et al., 1993). Other studies also showed
that, under some circumstances, Bcl3 could associate with
p50 or p52 homodimer, forming an activation complex on
the promoter (IkB:NF-kB:kB DNA), and therefore function to
coactivate NF-kB transcription (Bours et al., 1993; Dechend
et al., 1999; Fujita et al., 1993; Massoumi et al., 2006; Rocha
et al., 2003). Here we have shown how Bcl3 could accomplish
this dual role. Its oncogenic function may be linked to both
transcriptional activation and repression: through its continu-
ous presence, Bcl3 induces both uncontrolled proliferation and
inflammation.
In sum, we have shown how sequence variations in kB sites
diversify gene regulatory programs by imposing conformational
restrictions on bound NF-kBs. This work presents a descrip-
tion of rules that govern the in vivo transcriptional specificity of
NF-kB dimers, and describes how simultaneous activation and
repression by an NF-kB dimer are dictated by kB DNA response
elements. Our study sets the stage for genome-wide analysis
of the binding of p52:Bcl3 and other NF-kB dimers in correla-
tion with functions to fully elucidate the scope of response-
element-specific conformational variations in the pattern of
gene regulation.
EXPERIMENTAL PROCEDURES
Antibodies and Reagents
RelA (sc-372), tubulin (sc-5286), RNA Pol II (sc-900), HDAC3 (sc-11417),
normal rabbit IgG, and all secondary HRP-conjugated antibodies were
purchased from Santa Cruz Biotechnology. HDAC3 (ab7030) antibody was
obtained from Abcam. Flag (M2) (F3165) antibody and LPS (L6529) were ob-
tained from Sigma. Tip60 (07-038) was obtained from Millipore. p100/p52C(#1494 for ChIP assays and #1495 for western blot and EMSA) and Bcl3
(#1348) rabbit antisera were a gift from Dr. Nancy Rice (National Institutes of
Health, Bethesda, MD).
Mammalian Cell Culture
BMDMs were obtained from 5- to 7-week-old C57BL/6 mice as previously
described (Sawka-Verhelle et al., 2004). In brief, macrophages were cultured
in RPMI 1640 medium (Invitrogen) supplemented with 25% fetal bovine serum
(FBS) and 25%L-cell-conditionedmedium as a source ofmacrophage colony-
stimulating factor. RAW 264.7, HeLa, and HEK293T cells were grown in
Dulbecco’s modified Eagle’s medium (CellGro) supplemented with 10%
FBS, 2 mM glutamine, and antibiotics.
For RNA interference experiments, scramble control or smart-pool siRNAs
(Dharmacon) against Bcl3 were transfected into BMDM using Lipofectamine
2000 (Invitrogen) as previously described (Ghisletti et al., 2009). Cells were
used for experiments after 48 hr of incubation, and target gene knockdown
efficiency was validated by qPCR.
Protein Expressions and Purifications
Recombinant mouse RelA(19-304) and human p52(1-408) were expressed
and purified from Escherichia coli BL21(DE3) cells. Flag-Bcl3(1-446) was ex-
pressed in HEK293T cells using Lipofectamine 2000 (Invitrogen) for 48 hr
according to the manufacturer’s protocol, and purified with Anti-Flag M2
Affinity resin (A2220; Sigma).
Luciferase Reporter Assays
HeLa cells were transiently transfected with Flag-RelA(1-551), or Flag-
p52(1-415) together with Flag-Bcl3(1-446) expression vectors, and the lucif-
erase reporter DNAwith specific kBDNApromoters. Luciferase activity assays
were performed with the Dual-Luciferase Reporter Assay System (Promega)
following the manufacturer’s protocol. Details regarding the protocol are avail-
able in the Extended Experimental Procedures.
ChIP Assays
ChIP assays were performed in RAW 264.7 cells as previously described (Ghi-
sletti et al., 2009). The sequences of the promoter-specific primers are listed in
Table S1.
RNA Isolation and qRT-PCR
Total RNA (isolated by RNeasy kit; QIAGEN) was prepared from RAW
264.7 cells treated with LPS (100 ng/ml) as indicated; 0.1 mg of total RNA
was used for complementary DNA (cDNA) synthesis (SuperScriptIII First-
Strand Synthesis System; Invitrogen), and 1 ml of cDNA was used for
qRT-PCR analysis. Values were normalized to the glyceraldehyde 3-phos-
phate dehydrogenase (GAPDH) content (Livak and Schmittgen, 2001). Data
are represented as the mean ± standard deviation (SD) of three independent
experiments, each performed in duplicate. Primer sequences are listed in
Table S2.
Microarray Analysis
RNA was extracted from BMDM cells with the QIAGEN RNeasy kit and hybrid-
ized to Illumina Mouse RefSeq Sentrix-8 V2 BeadChip arrays at the University
of California-San Diego Biogem Facility. Probes with an 1.5-fold phenotype
in siBcl3 with siCTRL upon 8 hr of LPS (100 ng/ml) stimulation were selected
(biological duplicated samples). K-means clustering was performed with
selected probes.
EMSA
DNA-binding assays were performed using EMSA as previously described
(Moorthy et al., 2007). Sequences of the kB DNAs used are listed in Table S3.
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